These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 38817603)

  • 1. The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature.
    Warren A; Nyavor Y; Zarabian N; Mahoney A; Frame LA
    Front Immunol; 2024; 15():1365673. PubMed ID: 38817603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics.
    Ding M; Lang Y; Shu H; Shao J; Cui L
    Front Immunol; 2021; 12():742449. PubMed ID: 34707612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiota-Gut-Brain Axis.
    Cryan JF; O'Riordan KJ; Cowan CSM; Sandhu KV; Bastiaanssen TFS; Boehme M; Codagnone MG; Cussotto S; Fulling C; Golubeva AV; Guzzetta KE; Jaggar M; Long-Smith CM; Lyte JM; Martin JA; Molinero-Perez A; Moloney G; Morelli E; Morillas E; O'Connor R; Cruz-Pereira JS; Peterson VL; Rea K; Ritz NL; Sherwin E; Spichak S; Teichman EM; van de Wouw M; Ventura-Silva AP; Wallace-Fitzsimons SE; Hyland N; Clarke G; Dinan TG
    Physiol Rev; 2019 Oct; 99(4):1877-2013. PubMed ID: 31460832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Acute Central Nervous System Injury: A New Target for Therapeutic Intervention.
    Yuan B; Lu XJ; Wu Q
    Front Immunol; 2021; 12():800796. PubMed ID: 35003127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer's and Parkinson's Diseases.
    Ayten Ş; Bilici S
    Curr Nutr Rep; 2024 Jun; 13(2):82-96. PubMed ID: 38652236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota as a Mediator of Host Neuro-Immune Interactions: Implications in Neuroinflammatory Disorders.
    Caputi V; Popov J; Giron MC; O Apos Mahony S
    Mod Trends Psychiatry; 2021; 32():40-57. PubMed ID: 34032644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: A Microbial View of Central Nervous System Disorders: Interplay Between Microorganisms, Neuroinflammation and Behaviour.
    Cossu D; Watson RO; Farina C
    Front Immunol; 2021; 12():816227. PubMed ID: 34975927
    [No Abstract]   [Full Text] [Related]  

  • 8. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
    Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
    Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases.
    Cheng WY; Ho YS; Chang RC
    Ageing Res Rev; 2022 Jun; 78():101620. PubMed ID: 35405323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dangers of the chronic stress response in the context of the microbiota-gut-immune-brain axis and mental health: a narrative review.
    Warren A; Nyavor Y; Beguelin A; Frame LA
    Front Immunol; 2024; 15():1365871. PubMed ID: 38756771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
    Quigley EMM
    Curr Neurol Neurosci Rep; 2017 Oct; 17(12):94. PubMed ID: 29039142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease.
    Zhang W; Ye Y; Song J; Sang T; Xia T; Xie L; Qiu X; Zeng Q; Luo X
    J Integr Neurosci; 2023 Oct; 22(6):157. PubMed ID: 38176929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
    Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
    Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
    Ghaisas S; Maher J; Kanthasamy A
    Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome influences on neuro-immune interactions in neurodegenerative disease.
    Menees KB; Otero BA; Tansey MG
    Int Rev Neurobiol; 2022; 167():25-57. PubMed ID: 36427957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases.
    Cheng Y; Chen C; Zhang F
    Ageing Res Rev; 2023 Mar; 85():101857. PubMed ID: 36669690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.